SFTPD and cancer: Studies have demonstrated SP-D’s selective apoptotic effect on cancer cells with elevated High-Mobility Group A1 (HMGA1) expression, an oncogenic transcription factor overexpressed in various high-grade malignancies, while sparing healthy cells.